Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intensification and stem cell transplantation in adult acute lymphoblastic leukemia
NL-OMON20150Phase 2Active, not recruiting
- Sponsor
- HOVON
- Start
- Apr 1999
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of prednisone, vincristine, daunorubicin, asparaginase escherichia coli, methotrexate and 3 more in acute lymphoblastic leukemia (ALL) and acute undifferentiated leukemia (AUL) (2 arms), sponsored by HOVON. Primary endpoint: Response after each chemotherapy course and date of complete remission. Started Apr 1999; status: active, not recruiting.
02
Drugs
prednisonevincristinedaunorubicinasparaginase escherichia colimethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)acute undifferentiated leukemia (AUL)
Beyond the preview
Go deeper on NL-OMON20150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20150.